The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma

CONCLUSIONS: The key finding of this study was that the m6A methylation regulator gene has the main role in pancreatic tumors, and it may be used as a biomarker in the prognosis of the PAAD and for therapy purposes.PMID:34840598 | PMC:PMC8626177 | DOI:10.1155/2021/8715823
Source: Computational and Mathematical Methods in Medicine - Category: Statistics Authors: Source Type: research